Bargoni A - Search Results

1

Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin.

Cavalli R, Bargoni A, Podio V, Muntoni E, Zara GP, Gasco MR. Cavalli R, et al. Among authors: bargoni a. J Pharm Sci. 2003 May;92(5):1085-94. doi: 10.1002/jps.10368. J Pharm Sci. 2003. PMID: 12712429

2

Pharmacokinetics and tissue distribution of idarubicin-loaded solid lipid nanoparticles after duodenal administration to rats.

Zara GP, Bargoni A, Cavalli R, Fundarò A, Vighetto D, Gasco MR. Zara GP, et al. Among authors: bargoni a. J Pharm Sci. 2002 May;91(5):1324-33. doi: 10.1002/jps.10129. J Pharm Sci. 2002. PMID: 11977108

3

Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues.

Zara GP, Cavalli R, Bargoni A, Fundarò A, Vighetto D, Gasco MR. Zara GP, et al. Among authors: bargoni a. J Drug Target. 2002 Jun;10(4):327-35. doi: 10.1080/10611860290031868. J Drug Target. 2002. PMID: 12164381

4

Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats.

Bargoni A, Cavalli R, Caputo O, Fundarò A, Gasco MR, Zara GP. Bargoni A, et al. Pharm Res. 1998 May;15(5):745-50. doi: 10.1023/a:1011975120776. Pharm Res. 1998. PMID: 9619784

5

Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN).

Zara GP, Cavalli R, Fundarò A, Bargoni A, Caputo O, Gasco MR. Zara GP, et al. Among authors: bargoni a. Pharmacol Res. 1999 Sep;40(3):281-6. doi: 10.1006/phrs.1999.0509. Pharmacol Res. 1999. PMID: 10479474

6

Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats.

Fundarò A, Cavalli R, Bargoni A, Vighetto D, Zara GP, Gasco MR. Fundarò A, et al. Among authors: bargoni a. Pharmacol Res. 2000 Oct;42(4):337-43. doi: 10.1006/phrs.2000.0695. Pharmacol Res. 2000. PMID: 10987994

7

Transmucosal transport of tobramycin incorporated in SLN after duodenal administration to rats. Part I--a pharmacokinetic study.

Cavalli R, Zara GP, Caputo O, Bargoni A, Fundarò A, Gasco MR. Cavalli R, et al. Among authors: bargoni a. Pharmacol Res. 2000 Dec;42(6):541-5. doi: 10.1006/phrs.2000.0737. Pharmacol Res. 2000. PMID: 11058406

8

Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II--tissue distribution.

Bargoni A, Cavalli R, Zara GP, Fundarò A, Caputo O, Gasco MR. Bargoni A, et al. Pharmacol Res. 2001 May;43(5):497-502. doi: 10.1006/phrs.2001.0813. Pharmacol Res. 2001. PMID: 11394943

9

Intracellular accumulation and cytotoxicity of doxorubicin with different pharmaceutical formulations in human cancer cell lines.

Serpe L, Guido M, Canaparo R, Muntoni E, Cavalli R, Panzanelli P, Della Pepal C, Bargoni A, Mauro A, Gasco MR, Eandi M, Zara GP. Serpe L, et al. Among authors: bargoni a. J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):3062-9. doi: 10.1166/jnn.2006.423. J Nanosci Nanotechnol. 2006. PMID: 17048519

10

Solid lipid nanoparticles formed by solvent-in-water emulsion-diffusion technique: development and influence on insulin stability.

Battaglia L, Trotta M, Gallarate M, Carlotti ME, Zara GP, Bargoni A. Battaglia L, et al. Among authors: bargoni a. J Microencapsul. 2007 Nov;24(7):660-72. doi: 10.1080/02652040701532981. J Microencapsul. 2007. PMID: 17763060

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters